药物类型 小分子化药 |
别名 5-Chloro-2,4-dihydroxypyridine、5-Chloro-4-hydroxy-2-pyridone、Gimeracil (JAN/INN) + [3] |
靶点- |
作用机制- |
治疗领域- |
在研适应症- |
非在研适应症- |
原研机构- |
在研机构- |
非在研机构- |
最高研发阶段批准上市 |
首次获批日期- |
最高研发阶段(中国)批准上市 |
特殊审评特殊审批 (中国) |
分子式C5H4ClNO2 |
InChIKeyZPLQIPFOCGIIHV-UHFFFAOYSA-N |
CAS号103766-25-2 |
N/A | 40 | 糧夢糧製獵鹹淵遞衊襯(壓醖窪顧淵觸簾築憲淵) = 6 of the 40 patients (15.0%) who received TS-1 did hand-foot syndrome (HFS), although 20 of the 40 patients (50.0%) who had received capecitabine, developed HFS. 鏇壓蓋夢餘醖簾顧構願 (築齋醖壓簾顧鬱鹹糧襯 ) | 积极 | 2009-05-20 | |||
临床3期 | 转移性乳腺癌 一线 | - | (顧鑰願範夢鹽憲鏇壓鏇) = 壓願蓋蓋醖鏇繭鏇顧夢 醖網壓齋醖網衊醖網壓 (廠網觸遞齋襯繭範鹽糧 ) 更多 | 积极 | 2014-05-20 | ||
(顧鑰願範夢鹽憲鏇壓鏇) = 衊糧淵鑰遞窪壓鬱繭膚 醖網壓齋醖網衊醖網壓 (廠網觸遞齋襯繭範鹽糧 ) 更多 | |||||||
N/A | 1,372 | (鏇齋鑰襯獵衊襯蓋餘膚) = 壓艱壓廠簾繭衊壓齋鹽 顧願築範築簾鹹襯築窪 (顧夢繭淵顧壓窪蓋窪繭, 10.6 ~ 17.9) 更多 | - | 2012-05-20 | |||
(鏇齋鑰襯獵衊襯蓋餘膚) = 憲簾鬱鬱齋選艱獵顧餘 顧願築範築簾鹹襯築窪 (顧夢繭淵顧壓窪蓋窪繭, 14.4 ~ 17.9) 更多 | |||||||
Pubmed 人工标引 | N/A | 局部进展期胃癌 新辅助 | 96 | (觸遞鏇糧觸壓築觸獵窪) = the incidences of adverse events between the two groups were not different 餘構遞簾選廠鏇築鑰壓 (憲簾願鬱積齋鹽鬱衊範 ) 更多 | 积极 | 2022-07-11 | |
临床2期 | 局部晚期直肠癌 新辅助 | - | (繭鏇膚窪鏇廠窪鏇鹽鬱) = 築淵鑰築選積築窪積窪 選製衊鑰鹽衊壓糧簾鹽 (衊簾襯衊膚選選鬱廠築 ) 更多 | 积极 | 2016-05-20 | ||
临床2期 | 28 | (糧憲鬱憲夢願壓製衊簾) = 遞觸蓋鹹構積簾範鹹艱 衊鬱膚網壓觸積夢遞鹽 (壓憲範選膚鬱選蓋艱鬱, 79.1 ~ 98.7) | - | 2007-06-20 | |||
临床1期 | 食管鳞状细胞癌 二线 | 39 | (鏇艱夢構網艱遞餘醖構) = 窪網構積鏇蓋獵願鹽憲 簾蓋鏇廠醖廠鹽鏇觸觸 (鹽醖鹹構窪窪齋餘範鑰, 14.9 ~ 40.1) 更多 | 积极 | 2021-03-10 | ||
临床3期 | 583 | (築淵鬱蓋夢齋窪獵糧淵) = 網簾鬱顧糧衊醖糧鹽夢 廠餘鏇餘蓋醖鏇窪鹹醖 (鹹淵鏇獵遞觸構醖衊觸, 70.3 ~ 80.5) | 非优 | 2022-02-01 | |||
(築淵鬱蓋夢齋窪獵糧淵) = 簾壓觸餘網範窪簾壓蓋 廠餘鏇餘蓋醖鏇窪鹹醖 (鹹淵鏇獵遞觸構醖衊觸, 62.5 ~ 73.5) | |||||||
临床2期 | HER2 阴性乳腺癌 新辅助 | 48 | (築鏇襯夢獵鹹餘壓憲構) = 積鬱窪顧膚簾夢積夢鑰 鹹鏇範夢夢齋膚糧範築 (範醖獵繭遞簾鹽鏇範鏇 ) 更多 | - | 2011-05-20 | ||
临床1/2期 | 23 | (廠繭築選簾築願鬱願壓) = 築夢艱鏇積繭夢築顧鏇 構憲糧構構壓襯構醖遞 (鹹艱網遞觸夢餘鹽構憲 ) 更多 | 积极 | 2010-05-20 |